ASX - By Stock
|
DRO |
Re:
DRO - Chart and TA.
|
|
nottawombat
|
1.1K |
388K |
0 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
1.1K
|
388K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Response to ASX Aware Letter
|
|
nottawombat
|
25 |
12K |
0 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
25
|
12K
|
0
|
|
ASX - By Stock
|
PER |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
nottawombat
|
58 |
16K |
2 |
15/05/24 |
15/05/24 |
ASX - By Stock
|
58
|
16K
|
2
|
|
ASX - By Stock
|
DRO |
Re:
DRO - Chart and TA.
|
|
nottawombat
|
1.1K |
388K |
1 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
1.1K
|
388K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
DRO - Chart and TA.
|
|
nottawombat
|
1.1K |
388K |
2 |
14/05/24 |
14/05/24 |
ASX - By Stock
|
1.1K
|
388K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
nottawombat
|
153 |
59K |
2 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
153
|
59K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
nottawombat
|
153 |
59K |
1 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
153
|
59K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
nottawombat
|
199 |
49K |
1 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
199
|
49K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
nottawombat
|
199 |
49K |
2 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
199
|
49K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
nottawombat
|
153 |
59K |
2 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
153
|
59K
|
2
|
|
ASX - By Stock
|
IPD |
Re:
Ann: Notification of Quarterly Results & Investor, Revised
|
|
nottawombat
|
58 |
17K |
0 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
58
|
17K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
nottawombat
|
153 |
59K |
4 |
13/05/24 |
13/05/24 |
ASX - By Stock
|
153
|
59K
|
4
|
|
ASX - By Stock
|
DRO |
Re:
DRO - Chart and TA.
|
|
nottawombat
|
1.1K |
388K |
5 |
12/05/24 |
12/05/24 |
ASX - By Stock
|
1.1K
|
388K
|
5
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
nottawombat
|
153 |
59K |
2 |
29/04/24 |
29/04/24 |
ASX - By Stock
|
153
|
59K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
4 |
27/04/24 |
27/04/24 |
ASX - By Stock
|
719
|
174K
|
4
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
11 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
719
|
174K
|
11
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
1 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
719
|
174K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
2 |
25/04/24 |
25/04/24 |
ASX - By Stock
|
719
|
174K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
719
|
174K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
nottawombat
|
936 |
422K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
936
|
422K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
nottawombat
|
936 |
422K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
936
|
422K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
3 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
719
|
174K
|
3
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
719
|
174K
|
5
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
719
|
174K
|
7
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Two more PANCOSIL Trial treatments using OncoSil device
|
|
nottawombat
|
199 |
49K |
0 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
199
|
49K
|
0
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
719
|
174K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
719
|
174K
|
2
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
5 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
719
|
174K
|
5
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
nottawombat
|
936 |
422K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
936
|
422K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
7 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
719
|
174K
|
7
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
8 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
719
|
174K
|
8
|
|
ASX - By Stock
|
TLX Biotech |
Re:
Understanding Telix
|
|
nottawombat
|
936 |
422K |
6 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
936
|
422K
|
6
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Placement and Entitlement Offer to raise up to $7.1 million
|
|
nottawombat
|
118 |
32K |
1 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
118
|
32K
|
1
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
10 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
719
|
174K
|
10
|
|
ASX - By Stock
|
PER |
Re:
per-chart
|
|
nottawombat
|
719 |
174K |
7 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
719
|
174K
|
7
|
|
ASX - By Stock
|
DRO |
Re:
Ann: CEO 2024 AGM Presentation
|
|
nottawombat
|
10 |
3.7K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
10
|
3.7K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
Ann: CEO 2024 AGM Presentation
|
|
nottawombat
|
10 |
3.7K |
0 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
10
|
3.7K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
Ann: $70m Fully Underwritten Placement and up to $5m SPP
|
|
nottawombat
|
549 |
163K |
4 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
549
|
163K
|
4
|
|
ASX - By Stock
|
EOS |
Re:
Hot off the press!
|
|
nottawombat
|
1.6K |
845K |
0 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.6K
|
845K
|
0
|
|
ASX - By Stock
|
EOS |
Re:
Hot off the press!
|
|
nottawombat
|
1.6K |
845K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.6K
|
845K
|
1
|
|
ASX - By Stock
|
EOS |
Re:
Hot off the press!
|
|
nottawombat
|
1.6K |
845K |
1 |
22/04/24 |
22/04/24 |
ASX - By Stock
|
1.6K
|
845K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Trading Halt
|
|
nottawombat
|
72 |
20K |
1 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
72
|
20K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
Ann: Trading Halt
|
|
nottawombat
|
72 |
20K |
0 |
19/04/24 |
19/04/24 |
ASX - By Stock
|
72
|
20K
|
0
|
|
ASX - By Stock
|
DRO |
Re:
Ann: $70m Fully Underwritten Placement and up to $5m SPP
|
|
nottawombat
|
549 |
163K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
549
|
163K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix Q1 2024 Revenue and Business Update
|
|
nottawombat
|
153 |
59K |
5 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
153
|
59K
|
5
|
|
ASX - By Stock
|
ZIP |
Re:
Under $1 party
|
|
nottawombat
|
177 |
31K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
177
|
31K
|
2
|
|
ASX - By Stock
|
ZIP |
Re:
Under $1 party
|
|
nottawombat
|
177 |
31K |
3 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
177
|
31K
|
3
|
|
ASX - By Stock
|
DRO |
Re:
Ann: $70m Fully Underwritten Placement and up to $5m SPP
|
|
nottawombat
|
549 |
163K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
549
|
163K
|
1
|
|
ASX - By Stock
|
DRO |
Re:
Ann: $70m Fully Underwritten Placement and up to $5m SPP
|
|
nottawombat
|
549 |
163K |
2 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
549
|
163K
|
2
|
|
ASX - By Stock
|
DRO |
Re:
Ann: $70m Fully Underwritten Placement and up to $5m SPP
|
|
nottawombat
|
549 |
163K |
1 |
18/04/24 |
18/04/24 |
ASX - By Stock
|
549
|
163K
|
1
|
|